18 results on '"Kommoss, Stefan"'
Search Results
2. #142 An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC)
3. #556 Reproductive outcomes after fertility-sparing surgery for cervical cancer – results of the fertiss study
4. O031/#777 Lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease: results from the leopard trial
5. 21/#810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative
6. 3/#1042 Prognostic relevance of the molecular based ESMO/ESTRO/ESP2020 risk classification in endometrial carcinoma after surgical lymph node staging
7. O032/#771 Circulating HPV cell-free DNA in cervical cancer
8. EP222/#606 Acid ceramidase (ASAH1) expression is associated with improved overall survival in patients with high-grade serous ovarian cancer from the ICON-7 trial
9. EP115/#640 Are all stage IA p53abn endometrial cancers the same? Seeking clarity in the management of stage IA p53abn and/or non-endometrioid endometrial cancers without myometrial invasion
10. 2022-RA-1492-ESGO Homologous recombination deficiency (HRD): a new ovarian cancer biomarker – validation of decentralized genomic profiling, with a focus on genomic large rearrangements (LRs)
11. 2022-RA-995-ESGO Independent prognostic significance of substantial lymphovascular space invasion (LVSI) in a consecutive series of primary LVSI-positive endometrial carcinoma (EC)
12. 2022-RA-689-ESGO Fertility-sparing treatment in patients with IB1 cervical cancer – results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03)
13. 2022-RA-894-ESGO Endometrioid ovarian carcinoma – real world evidence from a large transatlantic team initiative: First results of the LEOPARD study
14. 2022-RA-1048-ESGO Circulating HPV cell-free DNA in cervical cancer
15. 2022-RA-906-ESGO Acid ceramidase(ASAH1)expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients
16. 2022-RA-798-ESGO Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II)
17. 284 Treatment strategies and survival of women with sex cord stroma cell tumours – an analysis of the ago-corsett database
18. 293 Treatment strategies and survival of women with malignant ovarian germ cell tumours – an analysis of the ago-corsett database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.